Commentary on "Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease" by Zimran et al.
Lysosomal Disorders Research and Treatment Unit, Center for Clinical Trials, O&O Alpan, Fairfax, VA, USA. ogokeralpan@oandoalpan.com
Ozlem
O
Goker-Alpan
D000551:Ambroxol / Q000627:therapeutic use*; D005260:Female; D005776:Gaucher Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male
D000551:Ambroxol